Navigation Links
NPC Conference to Address Questions on Ability to Share Health Research Findings
Date:2/6/2012

WASHINGTON, Feb. 6, 2012 /PRNewswire-USNewswire/ -- To examine key issues around asymmetries, or inequalities, in communicating health information coming from the growing body of comparative effectiveness research (CER), the National Pharmaceutical Council, the National Health Council and WellPoint are sponsoring a conference, Asymmetry in the Ability to Communicate CER Findings: Ethics and Issues for Informed Decision Making. 

With billions of dollars in funding being invested in comparative effectiveness research, patients, providers, payers and other health care decision-makers will have more information than ever before about the safety and effectiveness of treatment options. However, not all stakeholders have equal ability to share information in the current regulatory environment. The conference will facilitate discussion about the information needs of patients, payers and other stakeholders, and how the First Amendment and other legal issues apply. Presenters will share with attendees a proposed ethical framework for communicating CER information.

Who: Confirmed speakers include:

  • Arthur Caplan, PhD, Director, Center for Bioethics, University of Pennsylvania
  • Susan Dentzer, Editor-in-Chief, Health Affairs/Project HOPE
  • Robert W. Dubois, MD, PhD, Chief Science Officer, National Pharmaceutical Council
  • Scott Gottlieb, MD, Resident Fellow, American Enterprise Institute
  • Stephen Hume, PsyD, Alzheimer's patient representative, and his care partner, Candace Darcy
  • Aaron S. Kesselheim, MD, JD, MPH, Assistant Professor of Medicine, Harvard Medical School
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital
  • Joshua D. Lenchus, DO, RPh, FACP, Associate Director, University of Miami-Jackson Memorial Hospital Center for Patient Safety, and Associate Professor of Medicine, University of Miami Miller School of Medicine
  • Gerald F. Masoudi, Partner, Covington & Burling LLP
  • Steven J. Romano, MD, Senior Vice President, Head, Medicines Development Group, Primary Care Business, Pfizer Inc
  • Robert J. Temple, MD, Deputy Center Director for Clinical Science, U.S. Food and Drug Administration's (FDA's) Center for Drug Evaluation and Research, and Acting Deputy Director of the FDA's Office of Drug Evaluation I
  • Tevi Troy, PhD, Senior Fellow, Hudson Institute, and former Deputy Secretary, U.S. Department of Health and Human Services
  • Marcus Wilson, PharmD, President, HealthCore

When: Thursday, February 9, 2012, from 9:30 a.m. to 4:30 p.m.  The conference will open at 8:30 a.m. for registration and a continental breakfast.

Where:  Omni Shoreham Hotel, 2500 Calvert St. NW, Washington, D.C.  

Registration is complimentary at http://www.npcnow.org/asym12.     

To join the conversation on Twitter, use the hashtag #asym12.


'/>"/>
SOURCE National Pharmaceutical Council
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Webcast Alert: Heska Announces Fourth Quarter and Year-End 2011 Earnings Conference Call Webcast
2. Stryker Presents Results of the TREVO Prospective Clinical Study at the International Stroke Conference
3. American Pacific to Release Financial Results and Hold Fiscal 2012 First Quarter Investor Teleconference
4. CryoLife Announces Release Date and Teleconference Call Details for 2011 Fourth Quarter and Year End Financial Results
5. Winner Medical Group Inc. to Host First Quarter 2012 Earnings Conference Call on Thursday, February 9, 2012 at 08:00 p.m. EST
6. Vision-Sciences, Inc. to Webcast, Live, at RetailInvestorConferences.com on February 2nd
7. ThermoGenesis Provides Update on Res-Q® Clinical Evaluations at Leading Stem Cell Therapy Conference
8. Hill-Rom to Participate in the Leerink Swann 2012 Global Healthcare Conference
9. Auxilium Pharmaceuticals to Present at the Leerink Swann 2012 Global Healthcare Conference
10. Regeneron to Report Full Year 2011 Financial and Operating Results and Host Conference Call and Webcast on February 16, 2012
11. Palomar Medical Technologies to Host Fourth Quarter and Year End 2011 Financial Results Conference Call and Webcast on February 9, 2012 at 11:30 AM Eastern Time
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... , Dec. 8, 2016 KEY FINDINGS ... the largest share of the market in 2016 and ... dominance can be attributed to a large number of ... (US hold the largest share in the patient temperature ... benefits such as reducing loss of blood during surgeries, ...
(Date:12/8/2016)... 8, 2016 Research and Markets has announced ... Trends - Adhesion Type, Application, Usability - Forecast to 2025" ... , ... Market is poised to grow at a CAGR of around 3.2% ... market is witnessing include advancements in extracellular microelectrode arrays and intracellular ...
(Date:12/8/2016)... Quebec , Dec. 8, 2016  Valeant ... and TSX: VRX) ("Valeant") today announced positive results ... clinical study to assess the safety and efficacy ... the treatment of plaque psoriasis. ... subjects with moderate to severe psoriasis, IDP-118 showed ...
Breaking Medicine Technology:
(Date:12/9/2016)... ... December 09, 2016 , ... MEDI+SIGN®, a provider ... that a new solution for Emergency Departments (ED) has been added to their ... Emergency Department examination rooms, and with a simplified pallet of information available to ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... with distinction by the Undersea and Hyperbaric Medical Society (UHMS), the leading authority ... care and patient safety. Only a few hospitals and facilities have earned this ...
(Date:12/8/2016)... ... December 08, 2016 , ... Seavest ... Property owned by an affiliate of Seavest, has won a prestigious national healthcare ... Chester County ambulatory care center (ACC) was named “Best New Development, MOBs and ...
(Date:12/8/2016)... ... December 08, 2016 , ... David J. Dykeman , ... Greenberg Traurig, LLP, will speak at DeviceTalks West, Dec. 12, 2016, at the Fairmont ... and attorneys from the firm’s global Life Sciences & Medical Technology Group have been ...
(Date:12/8/2016)... ... 2016 , ... Catalent Pharma Solutions, the leading global provider ... products, today announced that it had joined the Pharmaceutical Supply Chain Initiative (PSCI). ... unite pharmaceutical and healthcare companies that share a vision of better, social, environmental ...
Breaking Medicine News(10 mins):